Baxter Boosts Its Full-Year Outlook After Topping Q2 Estimates
Baxter International (NYSE: BAX) reported mixed results when it announced its first-quarter update in April. Revenue decreased by 2% year over year while its adjusted earnings per share (EPS) rose by nearly 9%. Investors learned how Baxter performed in the second quarter on Thursday, with the healthcare company providing an update before the market opened. Here's what you need to know about Baxter's Q2 results.
Image source: Getty Images
Baxter reported revenue in Q2 of $2.8 million, just as it did in the prior-year period. The consensus among Wall Street analysts was for Q2 revenue of $2.79 billion.
Quelle Fool.com
